|
Nov 15
|
Natera, Inc. (NASDAQ:NTRA) Just Reported And Analysts Have Been Lifting Their Price Targets
|
|
Nov 15
|
Stanley Druckenmiller's Strategic Emphasis on Natera Inc in Q3 2024
|
|
Nov 14
|
Natera Third Quarter 2024 Earnings: Beats Expectations
|
|
Nov 13
|
Natera Stock Explodes 20% After Record-Breaking Q3--Is This Biotech Giant Just Getting Started?
|
|
Nov 13
|
Natera Inc (NTRA) Q3 2024 Earnings Call Highlights: Record Revenue and Raised Guidance Amid ...
|
|
Nov 12
|
Natera (NTRA) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
|
|
Nov 12
|
Natera (NTRA) Reports Q3 Loss, Tops Revenue Estimates
|
|
Nov 12
|
Natera: Q3 Earnings Snapshot
|
|
Nov 12
|
Natera Reports Third Quarter 2024 Financial Results
|
|
Nov 12
|
Natera Announces Completion of Signatera™ Analysis from the CALGB (Alliance)/SWOG 80702 Randomized, Phase III Clinical Trial in Colorectal Cancer
|
|
Sep 30
|
High Growth Tech Stocks To Watch In September 2024
|
|
Jul 30
|
Natera to Report its Second Quarter 2024 Results on August 8, 2024
|
|
Jul 29
|
Natera touts positive results for Merkel cell carcinoma surveillance test
|
|
Jul 26
|
New MultiCenter Prospective Study Demonstrates Signatera’s Clinical Utility in Merkel Cell Carcinoma
|
|
Jul 25
|
Natera (NTRA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
|
|
Jun 19
|
Insider Selling: CEO and President Steven Chapman Sells Shares of Natera Inc (NTRA)
|
|
Jun 17
|
Natera Launches Differentiated New Feature for Prospera™ Heart Test, Enhancing Detection of Rejection for Transplant Patients
|
|
May 31
|
Director Rowan Chapman Sells Shares of Natera Inc (NTRA)
|
|
May 30
|
Natera Presents Latest in Transplant Innovation Data Across Multiple Organs at ATC 2024
|
|
May 10
|
Why Natera Is 'A Stock To Focus On' Following Its Mighty Beat-And-Raise
|